2011年（平成23年）
Ohkusu-Tsukada K, Ohta S, Kawakami Y, Toda M.Adjuvant effects of formalin-inactivated HSV through activation of dendritic cells and inactivation of myeloid-derived suppressor cells in cancer immunotherapy.Int J Cancer.128:119-131,2011,Jan
Yaguchi T, Sumimoto H, Kudo-Saito C, Tsukamoto N, Ueda R, Iwata-Kajihara T, Nishio H, Kawamura N, Kawakami Y. The mechanisms of cancer immunoescape and development of overcoming strategies. Int J Hematol. 93:294-300,2011,Mar
Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, Ohyama M, Amagai M, Matsuzaki Y, Yamanaka S, Okano H, Kawakami Y. Generation of human melanocytes from induced pluripotent stem cells. PLOS ONE. 6(1):e16182,2011,Jan
Namiki T, Tanemura A, Valencia JC, Coelho SG, Passeron T, Kawaguchi M, Vieira WD, Ishikawa M, Nishijima W, Izumo T, Kaneko Y, atayama I, Yamaguchi Y, Yin L, Liu H, Kawakami Y, Eishi Y, Takahashi E, Yokozeki H,Hearing VJ. The AMPK-related kinase NUAK2 affects tumor growth, migration and clinical outcome of human melanoma. PNAS. 108(16):6597-602,2011
Tabuse M, Ohta S, Ohashi Y, Fukaya R, Misawa A, Yoshida K, Kawase T, Saya H, Thirant C, Hneiweiss H, Matsuzaki Y, Okano H, Kawakami Y, Toda M. Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells. Molecular Cancer. 10(1):60,2011
Iwata-Kajihara T, Sumimoto H, Kawamura n, Ueda R, Takahashi T, Mizuguchi H, Miyagishi M, Takeda K, Kawakami Y.Enhanced Cancer Immunotherapy Using STAT3-Depleted Dendritic cells with High Th1-Inducing Ability and Resistance to Cancer Cell-Derived Inhibitory Factors. J Immunol. 187(1):27-36,2011
Lisa H. Butterfield, A. Karolina Palucka, Cedrik M. Britten, Madhav V. Dhodapkar, Leif Ha kansson, Sylvia Janetzki, Yutaka Kawakami, Thomas-Oliver Kleen, Peter P. Lee, Cristina Maccalli, Holden T. Maecker, Vernon C. Maino, Michele Maio, Anatoli Malyguine, Giuseppe Masucci, Graham Pawelec, Douglas M. Potter, Licia Rivoltini, Lupe G. Salazar, Dolores J. Schendel, Craig L. Slingluff, Jr., Wenru Song, David F. Stroncek, Hideaki Tahara, Magdalena Thurin, Giorgio Trinchieri, Sjoerd H. van Der Burg, Theresa L. Whiteside, Jon M. Wigginton, Francesco Marincola, Samir Khleif, Bernard A. Fox, and Mary L. Disis.Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers. Clin Cancer Res. 17(10):3064-3076,2011
Bernard A. Fox, Dolores J. Schendel, Lisa H. Butterfield, Steinar Aamdal, James P. Allison, Paolo Antonio Ascierto, Michael B. Atkins, Jirina Bartunkova, Lothar Bergmann, Neil Berinstein, Jonathan L. Bramson, Cedrik M. Britten, William E. Carson, Dainius Characiejus, A. Raja Choudhury, George Coukos, Glenn Dranoff, James H. Finke, Jared A. Gollob, Cecile Gouttefangeas, Fabio Grizzi1, Michele Guida, Leif Håkansson, Kristen Hege, F. Stephen Hodi, Axel Hoos, Patrick Hwu, Howard L. Kaufman, Koji Kawakami, Yutaka Kawakami, Samir N. Khleif, Rolf Kiessling, Elizabeth M. Jaffee, Sylvia Janetzki, Carl H. June, Rejean Lapointe, Hyam I. Levitsky, Michele Maio, Jens-Peter Marschner, William J. Murphy, Cristina Maccalli, Giuseppe Masucci, Brad Nelson, Andrea Nicolini, Kunle Odunsi, Pamela S. Ohashi, Jill O’Donnell-Tormey, Lloyd J. Old, Christian Ottensmeier, Michael Papamichail, Giorgio Parmiani, Graham Pawelec, Enrico Proietti, Shukui Qin, Antoni Ribas, Ruggero Ridolfi, Gerd Ritter, Licia Rivoltini, Pedro J. Romero, Padmanee Sharma, Barbara Seliger, Hiroshi Shiku, Wenru Song, Per Thor Straten, Hideaki Tahara, Sjoerd H. van Der Burg, Paul von Hoegen, Ena Wang, Marij J. P. Welters, Jedd D. Wolchok, Heinz Zwierzina, Francesco M. Marincola, Thomas F. Gajewski, Jon M. Wigginton, Mary L. Disis. Defining the Critical Hurdles in Cancer Immunotherapy. J Transl Med.9:,2011
Ueda R, Yaguchi T, Kawakami Y. Human tumor antigens recognized by T cells and their implications for cancer immunotherapy in “Innate immune regulation and Cancer immunotherapy”, Wang RF ed, Springer Science. Business Media, New York USA. :335-345,2011
Takahashi S, Fusaki N, Ohta S, Iwahori Y, Iizuka Y, Inagawa K, Kawakami Y, Yoshida K, Toda M. Downregulation of KIF23 suppresses glioma proliferation. J Neuro-oncology106(3):519-29,2011